Chengcheng C Zhang from Southlake, TX, age 55

Resumes

Office Manager

view source

Location:

Dallas, TX

Industry:

Marketing And Advertising

Work:

Bella Diamanti
Office Manager
Cetetek 2013 - 2014
Sales Assistant

Education:

Dallas Baptist University 2015 - 2016
Dallas Baptist University 2012 - 2014
Masters, Media Studies, Communication, Communication Management

Skills:

Advertising
Digital Marketing
Microsoft Office
Marketing
Customer Service
Social Media
Public Speaking
Strategic Planning
Event Planning
Public Relations
Marketing Communications
Research

Interests:

Science and Technology
Children
Arts and Culture
Education

Languages:

English

Certifications:

Marketing

Chengcheng Zhang

view source

Us Patents

Ex Vivo Expansion Of Human Hematopoietic Stem Cells
view source
US Patent:

8609411, Dec 17, 2013
Filed:

May 2, 2008
Appl. No.:

12/598770
Inventors:

ChengCheng Zhang - Irving TX, US
Harvey Lodish - Brookline MA, US
Assignee:

Whitehead Institute for Biomedical Research - Cambridge MA
International Classification:

C12N 5/00
US Classification:

435375, 424 937, 435325
Abstract:

Methods and kits for expanding the number of hematopoietic stem cells are provided. The methods comprise incubating cells in medium comprising isolated IGFBP-2 and an angiopoietin-like protein (Angptl). Expanded HSCs are provided as well as culture media and kits for the expansion of human HSCs in a defined medium. Methods of administering expanded human HSCs to and individual are provided as well as methods of treating an individual by administering certain growth factors and cytokines.

Novel Lilrb2 Antibodies And Uses Thereof
view source
US Patent:

20230068663, Mar 2, 2023
Filed:

Jan 28, 2021
Appl. No.:

17/759800
Inventors:

- Austin TX, US
- Palo Alto CA, US
Zhiqiang KU - Houston TX, US
Chengcheng ZHANG - Southlake TX, US
Xiaoye XU - Dallas TX, US
Heyu CHEN - Dallas TX, US
JingJing XIE - Plano TX, US
Maria Jose COSTA - Palo Alto TX, US
An SONG - Palo Alto TX, US
Assignee:

THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM - Austin TX
IMMUNE-ONC THERAPEUTICS, INC. - Palo Alto CA
International Classification:

C07K 16/28
A61K 45/06
A61K 47/68
A61P 35/02
A61K 39/395
G01N 33/574
Abstract:

Provided herein are antibodies binding to LILRB2 and the uses of the antibodies in detecting and treating cancer and autoimmune diseases.

Anti-Lair1 Antibodies And Their Uses
view source
US Patent:

20190338026, Nov 7, 2019
Filed:

Jan 2, 2018
Appl. No.:

16/475223
Inventors:

- Austin TX, US
Qiang LIU - Palo Alto CA, US
Zhiqiang AN - Houston TX, US
Ningyan ZHANG - Houston TX, US
Xun GUI - Houston TX, US
Chengcheng ZHANG - Dallas TX, US
Mi DENG - Plano TX, US
Jingjing XIE - Plano TX, US
International Classification:

C07K 16/28
C12N 5/12
C12N 15/85
Abstract:

The present disclosure is directed to antibodies binding to LAIR 1 and their treating cancer, inflammation, immune-related diseases or transplantation.

Facebook

Chengcheng Zhang

view source

Friends:

Lu Peng, Carol Lei, Simon Shen, Justin Xie, Benson Weng

Chengcheng Zhang

view source

Friends:

Jiping Li, Wang Meng, Aronzo Lin, Charles Mui Zi Lek, Desa Palma, Yue Hu

Chengcheng Zhang

view source

News

Researchers Uncover Cancer’s Secret Weapon Against Immune Cells

view source

Reference: Secretogranin 2 binds LILRB4 resulting in immunosuppression by Xing Yang, Ryan Huang, Meng Fang, Yubo He, Jingjing Xie, Xiaoye Liu, Chengcheng Zhang, Qi Lou, Mi Deng, Wei Xiong, Cheryl Lewis, Zade Sadek, Ankit Gupta, Lianqi Chen, Xuewu Zhang, Lei Guo, Lin Xu, Ningyan Zhang, Zhiqiang An
Date: Aug 25, 2025
Category: Health
Source: Google